Table 2 Treatment-related adverse events
Adverse Event | N | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|---|
Hypothyroidism | 9 (37.5%) | 7 (29.2%) | 2 (8.3%) | ||
AST elevation | 6 (25%) | 1 (4.2%) | 1 (4.2%) | 4 (16.6%) | |
Pain | 6 (25%) | 5 (20.8%) | 1 (4.2%) | ||
Diarrhea | 5 (20.8%) | 2 (8.3%) | 3 (12.5%) | ||
Fatigue | 5 (20.8%) | 4 (16.6%) | 1 (4.2%) | ||
Rash | 5 (20.8%) | 4 (16.6%) | 1 (4.2%) | ||
Hypertension | 4 (16.6%) | 2 (8.3%) | 2 (8.3%) | ||
Nausea | 3 (12.5%) | 2 (8.3%) | 1 (4.2%) | ||
Hand-Foot syndrome | 2 (8.3%) | 1 (4.2%) | 1 (4.2%) | ||
Proteinuria | 2 (8.3%) | 2 (8.3%) | |||
Granulocytopenia | 2 (8.3%) | 1 (4.2%) | 1 (4.2%) | ||
Thrombocytopenia | 2 (8.3%) | 1 (4.2%) | 1 (4.2%) | ||
Anemia | 2 (8.3%) | 2 (8.3%) | |||
mucositis | 2 (8.3%) | 1 (4.2%) | 1 (4.2%) | ||
Edema | 2 (8.3%) | 2 (8.3%) | |||
Abdominal distension | 1 (4.2%) | 1 (4.2%) | |||
Elevated bilirubin | 1 (4.2%) | 1 (4.2%) | |||
Elevated creatinine | 1 (4.2%) | 1 (4.2%) | |||
Fever | 1 (4.2%) | 1 (4.2%) | |||
Hyperamylasemia | 1 (4.2%) | 1 (4.2%) |
